Abingworth

VC · London (United Kingdom)

VC

Seed

Series A

Healthcare

AI

Sign up free to access full profile and submit your pitch.

About

Abingworth is a transatlantic life sciences investment firm that partners with entrepreneurs to turn breakthrough science into medicine. Investing across all stages from seed to public companies, they focus on biopharma, therapeutics, medical devices, and diagnostics with offices in London, New York, and San Francisco.

Investment Criteria

Other investors that have backed the same portfolio companies as Abingworth. Expand any entry to see the shared portfolio companies.

• OrbiMed

  7 shared

  Shared portfolio companies

  • Adicet Bio, Inc.
  • Attenua, Inc.
  • Iambic Therapeutics, Inc.
  • Pathalys Pharma, Inc.
  • Q32 Bio Inc.
  • Scorpion Therapeutics, Inc.
  • X4 Pharmaceuticals, Inc.
• Novartis Venture Fund

  4 shared

  Shared portfolio companies

  • Adicet Bio, Inc.
  • eFFECTOR Therapeutics, Inc.
  • GenSight Biologics S.A.
  • Soteria Biotherapeutics, Inc.
• Omega Funds

  4 shared

  Shared portfolio companies

  • Antares Therapeutics, Inc.
  • Median Technologies SA
  • Newron Pharmaceuticals S.p.A.
  • Scorpion Therapeutics, Inc.
• Osage University Partners

  4 shared

  Shared portfolio companies

  • Atsena Therapeutics, Inc.
  • eFFECTOR Therapeutics, Inc.
  • Nido Biosciences, Inc.
  • Q32 Bio Inc.
• 4BIO Capital

  3 shared

  Shared portfolio companies

  • Ascend Gene & Cell Therapies Ltd.
  • Cytospire Therapeutics Limited
  • ENTACT BIO LIMITED
• 5AM Ventures

  3 shared

  Shared portfolio companies

  • Nido Biosciences, Inc.
  • Nouscom AG
  • Soteria Biotherapeutics, Inc.
• Bain Capital Life Sciences

  3 shared

  Shared portfolio companies

  • Atsena Therapeutics, Inc.
  • Timberlyne Therapeutics, Inc.
  • X4 Pharmaceuticals, Inc.
• Brandon Capital Partners Pty Ltd

  3 shared

  Shared portfolio companies

  • AdvanCell Isotopes Pty Ltd.
  • ENTACT BIO LIMITED
  • Myricx Pharma Ltd
• Catalio Capital Management

  3 shared

  Shared portfolio companies

  • AdvanCell Isotopes Pty Ltd.
  • Iambic Therapeutics, Inc.
  • Protara Therapeutics, Inc.
• Invus

  3 shared

  Shared portfolio companies

  • Antares Therapeutics, Inc.
  • GenSight Biologics S.A.
  • Scorpion Therapeutics, Inc.